MV
Mary Vasundra Justine
About Mary Vasundra Justine
Data last updated:
Mary Vasundra Justine is a Director at Novel Drugs Limited (since 2008). The companies operate in Pharma. Earlier, Mary Vasundra Justine was a Director at Medi Green Field Health Care Private Limited (from 2009).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novel Drugs Limited U24231TN1994PLC027710 | Director | 14 Aug 2008 | 1994 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Medi Green Field Health Care Private Limited U33100TN2009PTC070397 | Director | 06 Jan 2009 | 2009 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Mary Vasundra Justine
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chandra Gnanatilakan | 02326320 | Novel Drugs Limited | Director |
| Gnanatilakan Sebastian | 02301383 | Novel Drugs Limited | Director |
| Karunakaran Sebastin | 02335775 | Novel Drugs Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mary Vasundra Justine
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mary Vasundra Justine
Mary Vasundra Justine currently holds 1 directorship: Novel Drugs Limited (Director, since 14 Aug 2008).
Mary Vasundra Justine was first appointed on 14 Aug 2008 as Director at Novel Drugs Limited. The most recent appointment on record is 06 Jan 2009 at Medi Green Field Health Care Private Limited.
Mary Vasundra Justine held 1 earlier board appointment: Medi Green Field Health Care Private Limited (Director, from 06 Jan 2009).
The current boards of Mary Vasundra Justine's companies include Chandra Gnanatilakan (Novel Drugs Limited), Gnanatilakan Sebastian (Novel Drugs Limited), Karunakaran Sebastin (Novel Drugs Limited).